No Escrow. Licensee shall pay all Royalties and Non-Royalty Sublicense Revenue directly to CSMC and shall not pay royalties into any escrow or other similar account, including in the event of a validity or non-infringement challenge to the Patent Rights.
Appears in 11 contracts
Sources: Exclusive Option Agreement (Kairos Pharma, LTD.), Exclusive Option Agreement (Kairos Pharma, LTD.), Exclusive License Agreement (Kairos Pharma, LTD.)
No Escrow. Licensee shall pay all Royalties and Non-Royalty Sublicense Revenue Fees directly to CSMC and shall not pay royalties into any escrow or other similar account, including in the event of a validity or non-infringement challenge to the Patent Rights.
Appears in 1 contract
Sources: Exclusive License Agreement (ImmunoCellular Therapeutics, Ltd.)